Eucrates Biomedical Acquisition Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $5,537,788 over the previous period. Total operating expenses were $698,578.
Profit Margin
| 2020 | 0 | 8.59K | |
|---|---|---|---|
| 2021 | 0 | 3.82M | |
| 2022 | 0 | 5.53M |
EUCR Income Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 |
Operating exp. | |||
Research and development | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 698.57K | 743.07K | 8.59K |
Operating income | -698.57K | -743.07K | 8.59K |
Other income (expenses), net | 3.11M | 4.56M | 0 |
Income before tax | 2.41M | 3.82M | 8.59K |
Income tax expense | -3.11M | -35.76K | 0 |
Net income | 5.53M | 3.82M | 8.59K |
Earnings per share | |||
Basic EPS | 1.86 | 1.28 | 0.00 |
Diluted EPS | 1.86 | 0.28 | 0.00 |
| Data source | Data source | Data source |